Exciting news for the Oncology Institute as they are set to join the prestigious Russell 2000 and Russell 3000 Indexes. The annual reconstitution of the Russell indexes has identified the 4,000 largest US stocks as of April 30, ranking them based on total market capitalization. Membership in the US all-cap Russell 3000 Index guarantees automatic inclusion in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index, along with the appropriate growth and value style indexes. FTSE Russell’s selection process for its Russell indexes is primarily based on objective market-capitalization rankings and style attributes. This move signifies a significant milestone for the Oncology Institute, showcasing its growth and value in the oncology sector within the US stock market.
Read more about this — here
